Search all trials

Find therapies in clinical trials near you – page 13

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Hormone receptor positive HER2 negative breast cancer

Recruiting

Registered drug

Study on Elacestrant and Everolimus for Patients with Advanced ER+/HER2- Breast Cancer Resistant to Endocrine Therapy and CDK4/6 Inhibitors

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Elacestrant

Contact Research Centre

Neoplasm malignant

Recruiting

Registered drugNo placebo

Study of ART6043, Olaparib, and Niraparib in Patients with Advanced or Metastatic Solid Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Art6043

Contact Research Centre

Cardiac failure acute

Recruiting

Registered drugNo placebo

Study on Using Furosemide and Hydrochlorothiazide for Treating Patients with Acute Heart Failure

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Furosemide

Contact Research Centre

Small cell lung cancer extensive stage

Recruiting

Registered drugNo placebo

Study of Ifinatamab Deruxtecan with Atezolizumab and Carboplatin for Patients with Extensive-Stage Small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study of Sacituzumab and Zimberelimab for Patients with Resectable Non-Small Cell Lung Cancer After Surgery Without Complete Disease Clearance

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Zimberelimab

Contact Research Centre

Neoplasm malignant+1

Recruiting

Registered drugNo placebo

Study on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Binimetinib

Contact Research Centre

Squamous cell carcinoma of lung+2

Recruiting

Registered drugNo placebo

Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

HER2 gene amplification

Recruiting

InvestigationalNo placebo

Study of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Zongertinib

Contact Research Centre

Bronchopulmonary dysplasia

Recruiting

InvestigationalNo placebo

Safety Study of Mesenchymal Cells for Preterm Infants with Bronchopulmonary Dysplasia

InvestigationalNo placebo

Spain

Participants:0–17 years
Substances:Mesenchymal Cells

Contact Research Centre

B-cell lymphoma recurrent

Recruiting

Registered drugNo placebo

Study on Axicabtagene Ciloleucel for Patients with Late Relapse of Diffuse Large B-Cell Lymphoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Non-small cell lung cancer stage III+3

Recruiting

Registered drugNo placebo

Study of Volrustomig and Drug Combination for Patients with Early-stage Resectable Non-small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Adagrasib

Contact Research Centre

Find therapies in clinical trials near you – page 13

575 trials match your criteria

Hormone receptor positive HER2 negative breast cancer

Study on Elacestrant and Everolimus for Patients with Advanced ER+/HER2- Breast Cancer Resistant to Endocrine Therapy and CDK4/6 Inhibitors

Neoplasm malignant

Study of ART6043, Olaparib, and Niraparib in Patients with Advanced or Metastatic Solid Tumors

Cardiac failure acute

Study on Using Furosemide and Hydrochlorothiazide for Treating Patients with Acute Heart Failure

Small cell lung cancer extensive stage

Study of Ifinatamab Deruxtecan with Atezolizumab and Carboplatin for Patients with Extensive-Stage Small Cell Lung Cancer

Non-small cell lung cancer

Study of Sacituzumab and Zimberelimab for Patients with Resectable Non-Small Cell Lung Cancer After Surgery Without Complete Disease Clearance

Neoplasm malignant+1

Study on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors

Squamous cell carcinoma of lung+2

Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance

HER2 gene amplification

Study of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes

Bronchopulmonary dysplasia

Safety Study of Mesenchymal Cells for Preterm Infants with Bronchopulmonary Dysplasia

B-cell lymphoma recurrent

Study on Axicabtagene Ciloleucel for Patients with Late Relapse of Diffuse Large B-Cell Lymphoma

Non-small cell lung cancer stage III+3

Study of Volrustomig and Drug Combination for Patients with Early-stage Resectable Non-small Cell Lung Cancer

Non-small cell lung cancer

Study of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.